Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI ( (CLBT) ) has issued an announcement.
Cellebrite announced its second-quarter 2025 financial results, highlighting an 18% increase in revenue to $113.3 million and a 21% rise in annual recurring revenue to $418.9 million. The company appointed Thomas E. Hogan as CEO, who emphasized strategic progress, including the pending acquisition of Corellium and advancements in FedRAMP compliance. These developments are expected to enhance Cellebrite’s market position and drive growth in both public and private sectors.
The most recent analyst rating on (CLBT) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.
Cellebrite DI’s overall stock score is driven primarily by strong financial performance and positive earnings call highlights. However, technical analysis shows bearish signals, and valuation is impacted by net losses and the absence of a dividend yield. The company’s growth outlook is positive, but current net profitability challenges and market technicals moderate the overall score.
To see Spark’s full report on CLBT stock, click here.
More about Cellebrite DI
Cellebrite DI Ltd. is a global leader in digital investigative solutions, serving both public and private sectors. The company specializes in providing advanced tools for digital forensics and investigation, focusing on enhancing public safety and security.
Average Trading Volume: 1,510,068
Technical Sentiment Signal: Hold
Current Market Cap: $3.33B
Learn more about CLBT stock on TipRanks’ Stock Analysis page.